Vital Signs wins Premier contract:
This article was originally published in Clinica
Premier, the US healthcare alliance, has granted a dual- source supply agreement to Marquest Medical Products, which is to be acquired by Vital Signs. Under the terms of the five-year deal, Premier member hospitals will buy 80% of required arterial blood gas kits from Marquest and one other company.
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.